Oridonin enhances phagocytosis of UV-irradiated apoptotic U937 cells

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 3, 2005, Pages 461-467

  Liu, Yan Qiu ^a   You, Song ^a   Zhang, Chun Ling ^a   Tashiro, Shin Ichi ^b   Onodera, Satoshi ^b   Ikejima, Takashi ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; IL 1 ; Macrophages; Oridonin; Phagocytosis; TNF

Indexed keywords

ANTISERUM; INTERLEUKIN 1BETA; MICROSPHERE; ORIDONIN; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG SELECTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; PHAGOCYTOSIS; RABDOSIA; RABDOSIA RUBESCENS; ULTRAVIOLET IRRADIATION;

APOPTOSIS; CELLS, CULTURED; DITERPENES; DITERPENES, KAURANE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MONOCYTES; PHAGOCYTOSIS; U937 CELLS; ULTRAVIOLET RAYS;

EID: 21144445684     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.461     Document Type: Article

References (28)

1. Fujita T., Takeda Y., Sun H. D., Minami Y., Marunaka T., Takeda S., Planta Medica, 54, 414-417 (1988).
2. Osawa K., Yasuda H., Maruyama T., Morita H., Takeya K., Itokawa H., Phytochemistry, 36, 1287-1291 (1994).
3. Zhang Y., Wang J., Lou L. G., Zhang T. M., Hou J. W., Xin W. J., Henan Medical Research, 8, 100-104 (1999).
4. Zhang C. L., Wu L. J., Tashiro S., Onodera S., Ikejima T., Acta Pharmacol. Sin., 25, 691-698 (2004).
5. Zhang C. L., Wu L. J., Tashiro S., Onodera S., Ikejima T., J. Asian Nat. Prod. Res., 6, 127-138 (2004).
6. Kerr J. F. R., Winterford C. M., Harmon B. V., Cancer, 73, 2013-2026 (1994).
7. Savill J., Fadok V. A., Nature (London), 407, 784-788 (2000).
8. Cohen J. J., Adv. Immunol., 50, 55-85 (1991).
9. Savill J., Fadok V., Henson P., Haslett C., Immunol. Today, 14, 131-136 (1993).
10. Hughes J., Liu Y., Van Damme J., J. Immunol., 158, 4389-4397 (1997).
11. Savill J., Fadok V., Nature (London), 407, 784-788 (2000).
12. Ren Y., Savill J., J. Immunol., 154, 2366-2374 (1995).
13. Anderson H. A., Maylock C. A., Williams J. A., Paweletz C. P., Shu H. J., Shacter E., Nat. Immunol., 4, 87-91 (2002).
14. Bogdan C., Ding A., J. Leukoc. Biol., 52, 119-121 (1992).
15. Shah V., Bayeta E., Lau B. H. S., Pakistan J. Nutr., 1, 196-201 (2002).
16. Sampson L. L., Heuser J., Brown E. J., J. Immunol., 146, 1005-1013 (1991).
17. Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T., Ann. Rev. Biochem., 59, 783-836 (1990).
18. Doherty D. E., Haslett E. C., Tonnesen M. G., Henson P. M., J. Immunol., 136, 1762-1771 (1987).
19. Park J. M., Greten F. R., Li Z. W, Karin M., Science, 297, 2048-2051 (2002).
20. Mullins D. W., Burger C. J., Elgert K. D., Int. J. Immunolpharmacol., 20, 537-551 (1998).
21. Haslett C., Clin. Sci., 83, 639-648 (1992).
22. Bartholeyns J., Res. Immunol., 144, 288-298 (1993).
23. Currie G. A., Bashan C., J. Exp. Med., 142, 1600-1605 (1975).
24. Gupta S., J. Rheumatol., S76, 189-201 (1988).
25. Becker S., J. Immunol., 132, 1249-1254 (1984).
26. Fleischmann J., Golde D. W., Weisbart R. H., Gasson J. C., Blood, 68, 708-711 (1986).
27. Te Velde A. A., Klomp J. P. G., Yard B. A., deVries J. E., Figdor C. G., J. Immunol., 140, 1548-1554 (1988).
28. Zuckerman S. H., Surprenant Y. M., Tang J., Blood, 71, 619-624 (1988).